![Michael Hodges](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Hodges
Directeur/Membre du Conseil chez
TELESIS BIO, INC.
Profil
Michael R Hodges is currently Chief Executive Officer at 1Strand since 2020.
Dr. Hodges is Director at Telesis Bio, Inc. starting in 2024.
Dr. Hodges is Director at Hybridize Therapeutics.
Dr. Hodges is Director at AbVacc, Inc. Dr. Hodges is Partner at Claris Ventures Sgr SpA since 2023.
Dr. Hodges is Senior Advisor at Adjuvant Capital LP.
Dr. Hodges is Advisor at eFFECTOR Therapeutics, Inc. Dr. Hodges is Board Member at Resalis Therapeutics SRL since 2021.
Former roles include Non-Executive Director at F2G Ltd. from 2010 to 2014, Principal at Pfizer Inc., Chief Medical Officer at Kémia, Inc., Chief Medical Officer & Head-Dug Development at Roche Innovation Center Copenhagen A, Principal at Kent County Memorial Hospital in 2001, Chief Medical Officer at Altair Therapeutics, Inc. from 2009 to 2011, Chief Medical Officer at Amplyx Pharmaceuticals, Inc. from 2016 to 2021, Principal at St. Thomas Hospital, Inc. in 1990, Senior Medical Advisor at US Air Force from 2018 to 2021, and Advisor at Arcturus Therapeutics Holdings, Inc. Education includes undergraduate and graduate degrees from East Carolina University in 1993, undergraduate and doctorate degrees from the University of London, an undergraduate degree from The King's College (New York), a graduate degree from Wright State University (Ohio) in 2012, and a doctorate from Brody School of Medicine in 1999.
Postes actifs de Michael Hodges
| Sociétés | Poste | Début |
|---|---|---|
| EFFECTOR THERAPEUTICS, INC. | Consultant / Advisor | - |
| TELESIS BIO, INC. | Directeur/Membre du Conseil | 01/07/2024 |
Adjuvant Capital LP
 Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences. It provides equity, mezzanine and debt financing for later stage capital requirements with an investment size of USD 10 to 25 million. | Consultant / Advisor | - |
Hybridize Therapeutics | Directeur/Membre du Conseil | - |
Resalis Therapeutics SRL
 Resalis Therapeutics SRL Miscellaneous Commercial ServicesCommercial Services Engages in development of oligonucleotide anti-sense therapies to treat metabolic disorders | Directeur/Membre du Conseil | 01/01/2021 |
Claris Ventures Sgr SpA
 Claris Ventures Sgr SpA Investment ManagersFinance Claris Ventures invests in companies located in Italy. The firm focuses on the biotech sector with an investment size of EUR 5 - 15 million. It provides financing for early stage capital requirements. | Private Equity Investor | 01/01/2023 |
AbVacc, Inc.
 AbVacc, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on the discovery of novel vaccines | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Hodges
| Sociétés | Poste | Fin |
|---|---|---|
US Air Force
 US Air Force SovereignGovernment Provides aerial warfare and space warfare services | Consultant / Advisor | 30/06/2021 |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes medicines | Directeur Technique/Scientifique/R&D | 01/06/2021 |
| ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Michael Hodges
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
39
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Kémia, Inc.
 Kémia, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel small molecule therapeutics | Health Technology |
East Carolina University
 East Carolina University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The King's College (New York)
 The King's College (New York) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Health Technology |
Wright State University (Ohio)
 Wright State University (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kent County Memorial Hospital
 Kent County Memorial Hospital Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Health Technology |
Altair Therapeutics, Inc.
 Altair Therapeutics, Inc. Medical DistributorsDistribution Services Discovers, develops and commercializes antisense drugs | Distribution Services |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes medicines | Health Technology |
St. Thomas Hospital, Inc.
 St. Thomas Hospital, Inc. Hospital/Nursing ManagementHealth Services Operates hospitals | Health Services |
US Air Force
US Air Force SovereignGovernment Provides aerial warfare and space warfare services | Government |
Brody School of Medicine
 Brody School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Claris Ventures Sgr SpA
Claris Ventures Sgr SpA Investment ManagersFinance Claris Ventures invests in companies located in Italy. The firm focuses on the biotech sector with an investment size of EUR 5 - 15 million. It provides financing for early stage capital requirements. | Finance |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences. It provides equity, mezzanine and debt financing for later stage capital requirements with an investment size of USD 10 to 25 million. | Finance |
Telesis Bio, Inc.
 Telesis Bio, Inc. Medical SpecialtiesHealth Technology Engages in R&D, manufacturing and sale of synthetic biology instruments | Health Technology |
Arcturus Therapeutics Holdings, Inc.
 Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Resalis Therapeutics SRL
Resalis Therapeutics SRL Miscellaneous Commercial ServicesCommercial Services Engages in development of oligonucleotide anti-sense therapies to treat metabolic disorders | Commercial Services |
Hybridize Therapeutics | |
AbVacc, Inc.
AbVacc, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on the discovery of novel vaccines | Health Technology |
